Tenaya Therapeutics, Inc. (TNYA) stock
TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32−0.01 (-3.24%)
Close on Nov 17, 2026Market cap $72.38MP/E –Yield –
Tenaya Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tenaya Therapeutics's enterprise value was $5.13M on Nov 11, 2026, against $126.55M a year earlier. Over the last 5 years it ranged from -$190.54M to $301.97M, with a median of $52.70M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.13M | -86.0% |
| 2025 | Dec 31, 2025 | $36.63M | -2.3% |
| 2024 | Dec 31, 2024 | $37.49M | -60.7% |
| 2023 | Dec 29, 2023 | $95.29M | -26.4% |
| 2022 | Apr 29, 2022 | $129.41M | – |
| 2021 | Dec 31, 2021 | -$137.48M | – |
See a number that looks wrong?